Want to see AU:VIT full AI Analyst Report?
VIT Stock Chart & Stats
AU$0.06
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.06
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.08
Previous CloseN/A
Volume1.00K
Average Volume (3M)228.84K
Market Cap
AU$20.54M
Enterprise ValueAU$49.17
Total Cash (Recent Filing)AU$6.10M
Total Debt (Recent Filing)AU$17.34M
Price to Earnings (P/E)25.0
Beta1.62
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield6.67%
Share Statistics
EPS (TTM)<0.01
Shares Outstanding662,741,800
10 Day Avg. Volume238,134
30 Day Avg. Volume228,844
Financial Highlights & Ratios
PEG Ratio-1.00
Price to Book (P/B)0.78
Price to Sales (P/S)0.30
P/FCF Ratio14.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Leverage & Strong Equity BaseA low debt-to-equity ratio and high equity ratio give Cronos Australia durable financial flexibility. Conservatively leveraged balance sheets reduce refinancing risk, support resilience through industry cycles, and enable spending on R&D or capacity without overreliance on external debt.
Stable Gross MarginA roughly 27% gross margin indicates persistent product-level profitability and cost control. Stable gross margins provide a structural cushion allowing the company to invest in go-to-market activities or absorb input cost swings while pursuing margin expansion at the EBITDA/net level over the medium term.
Positive Return On EquityA positive ROE near 7% shows the business generates returns on shareholder capital rather than destroying it. While moderate, this indicates some operating effectiveness and the potential to compound shareholder value if revenue growth and operational efficiency improve over coming quarters.
Bears Say
Severe Free Cash Flow DeclineAn extreme drop in free cash flow growth signals a structural deterioration in cash generation. This undermines the company's ability to self-fund capex, operations, or distributions and increases reliance on external financing, which can constrain strategic investments and raise long-term financing costs.
Poor Cash ConversionLow conversion of reported earnings into operating cash suggests earnings quality issues or working-capital pressure. Persistently weak cash conversion impairs liquidity, limits reinvestment capacity, and heightens vulnerability to revenue shocks or tighter financing conditions over the medium term.
Weak Revenue Trend & Thin Net MarginsA modest revenue decline combined with very thin net and operating margins points to competitive pressure or limited pricing power. Structural revenue weakness and low margins reduce internal funding for growth initiatives and make the business more sensitive to cost increases or market downturns.
Cronos Australia Ltd. News
VIT FAQ
What was Cronos Australia Ltd.’s price range in the past 12 months?
Cronos Australia Ltd. lowest share price was AU$0.02 and its highest was AU$0.07 in the past 12 months.
What is Cronos Australia Ltd.’s market cap?
Cronos Australia Ltd.’s market cap is AU$20.54M.
When is Cronos Australia Ltd.’s upcoming earnings report date?
Cronos Australia Ltd.’s upcoming earnings report date is Aug 26, 2026 which is in 36 days.
How were Cronos Australia Ltd.’s earnings last quarter?
Cronos Australia Ltd. released its earnings results on Feb 25, 2026. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Cronos Australia Ltd. overvalued?
According to Wall Street analysts Cronos Australia Ltd.’s price is currently Overvalued.
Does Cronos Australia Ltd. pay dividends?
Cronos Australia Ltd. pays a Annually dividend of AU$0.002 which represents an annual dividend yield of 6.67%. See more information on Cronos Australia Ltd. dividends here
What is Cronos Australia Ltd.’s EPS estimate?
Cronos Australia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cronos Australia Ltd. have?
Cronos Australia Ltd. has 662,741,800 shares outstanding.
What happened to Cronos Australia Ltd.’s price movement after its last earnings report?
Cronos Australia Ltd. reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
Which hedge fund is a major shareholder of Cronos Australia Ltd.?
Currently, no hedge funds are holding shares in AU:VIT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Australia Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.51%
12-Months-Change
Fundamentals
Return on Equity
6.67%
Trailing 12-Months
Asset Growth
8.56%
Trailing 12-Months
Company Description
Cronos Australia Ltd.
Established in 2018 and based in South Yarra, Australia, Vitura Health Limited focuses on the supply and marketing of medicinal cannabis goods throughout Australia and the Asian market. The company manages a portfolio of key brands, such as CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. This entity was formerly recognized as Cronos Australia Limited before adopting the name Vitura Health Limited in February 2023.
Technical Analysis
Elixinol Wellness
―
Cann Group
―
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Althea Group Holdings Ltd.
―